Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value ($000): $406,144 (100.0% shares, 0.0% debt)

Holdings (30)

NBP I MAB 13.6%

Value ($000) $55,416 Shares 764,461 Est. Cost $63.37 Unrealized —

APLS APELLIS PHARMACEUTICALS INC 13.0%

Value ($000) $52,601 Shares 1,595,911 Est. Cost $49.38 Unrealized +13.8%

CLDX CELLDEX THERAPEUTICS INC NEW 10.1%

Value ($000) $41,108 Shares 761,398 Est. Cost $25.60 Unrealized +83.3%

RCUS ARCUS BIOSCIENCES INC 8.3%

Value ($000) $33,830 Shares 970,164 Est. Cost $28.41 Unrealized +9.5%

BBIO BRIDGEBIO PHARMA INC 6.6%

Value ($000) $26,688 Shares 569,414 Est. Cost $55.95 Unrealized -4.2%

FDMT 4D MOLECULAR THERAPEUTICS IN 5.5%

Value ($000) $22,419 Shares 831,267 Est. Cost $35.47 Unrealized -19.6%

GOSS GOSSAMER BIO INC 4.7%

Value ($000) $19,020 Shares 1,513,138 Est. Cost $9.81 Unrealized -6.1%

— CURIS INC 4.4%

Value ($000) $17,968 Shares 2,294,721 Est. Cost $8.14 Unrealized —

IPSC CENTURY THERAPEUTICS INC 3.7%

Value ($000) $15,162 Shares 602,623 Est. Cost $25.93 Unrealized +4.4%

ARVN ARVINAS INC 3.4%

Value ($000) $13,847 Shares 168,500 Est. Cost $34.48 Unrealized +156.3%

VERA VERA THERAPEUTICS INC 3.0%

Value ($000) $12,078 Shares 696,126 Est. Cost $15.54 Unrealized +15.1%

RNAM AVIDITY BIOSCIENCES INC 2.7%

Value ($000) $11,001 Shares 446,641 Est. Cost $28.99 Unrealized -25.0%

CTKB CYTEK BIOSCIENCES INC 2.6%

Value ($000) $10,705 Shares 500,000 Est. Cost $23.52 Unrealized 0.0%

DYN DYNE THERAPEUTICS INC 2.3%

Value ($000) $9,478 Shares 583,649 Est. Cost $19.71 Unrealized -10.0%

— CONNECT BIOPHARMA HLDGS LTD 1.9%

Value ($000) $7,795 Shares 326,143 Est. Cost $18.50 Unrealized —

STOK STOKE THERAPEUTICS INC 1.9%

Value ($000) $7,551 Shares 296,822 Est. Cost $35.35 Unrealized -21.1%

— OMEGA THERAPEUTICS INC 1.7%

Value ($000) $6,980 Shares 370,279 Est. Cost $18.85 Unrealized —

CRDF CARDIFF ONCOLOGY INC 1.6%

Value ($000) $6,545 Shares 982,753 Est. Cost $14.50 Unrealized -56.7%

— PROMETHEUS BIOSCIENCES INC 1.2%

Value ($000) $4,742 Shares 200,000 Est. Cost $18.26 Unrealized —

— AMBRX BIOPHARMA INC 1.2%

Value ($000) $4,725 Shares 350,000 Est. Cost $19.60 Unrealized —

— IVERIC BIO INC 1.1%

Value ($000) $4,499 Shares 277,057 Est. Cost $6.91 Unrealized —

— NGM BIOPHARMACEUTICALS INC 1.0%

Value ($000) $4,204 Shares 200,000 Est. Cost $29.53 Unrealized —

MLTX HELIX ACQUISITION CORP 1.0%

Value ($000) $3,948 Shares 400,000 Est. Cost $11.37 Unrealized —

— IKENA ONCOLOGY INC 0.9%

Value ($000) $3,471 Shares 275,000 Est. Cost $28.25 Unrealized —

GLUE MONTE ROSA THERAPEUTICS INC 0.8%

Value ($000) $3,342 Shares 150,000 Est. Cost $20.37 Unrealized +40.7%

PMVP PMV PHARMACEUTICALS INC 0.7%

Value ($000) $2,984 Shares 100,141 Est. Cost $39.23 Unrealized -18.6%

— JIYA ACQUISITION CORP 0.7%

Value ($000) $2,934 Shares 300,000 Est. Cost $10.30 Unrealized —

EWTX EDGEWISE THERAPEUTICS INC 0.2%

Value ($000) $830 Shares 50,000 Est. Cost $32.43 Unrealized -44.2%

DSGN DESIGN THERAPEUTICS INC 0.1%

Value ($000) $219 Shares 14,926 Est. Cost $31.14 Unrealized -46.6%

— TENAX THERAPEUTICS INC 0.0%

Value ($000) $54 Shares 30,600 Est. Cost $1.76 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
NBP	I MAB	764,461	$55,416	13.6%	$63.37	—	SPONSORED ADS	44975P103
APLS	APELLIS PHARMACEUTICALS INC	1,595,911	$52,601	13.0%	$49.38	+13.8%	COM	03753U106
CLDX	CELLDEX THERAPEUTICS INC NEW	761,398	$41,108	10.1%	$25.60	+83.3%	COM NEW	15117B202
RCUS	ARCUS BIOSCIENCES INC	970,164	$33,830	8.3%	$28.41	+9.5%	COM	03969F109
BBIO	BRIDGEBIO PHARMA INC	569,414	$26,688	6.6%	$55.95	-4.2%	COM	10806X102
FDMT	4D MOLECULAR THERAPEUTICS IN	831,267	$22,419	5.5%	$35.47	-19.6%	COM	35104E100
GOSS	GOSSAMER BIO INC	1,513,138	$19,020	4.7%	$9.81	-6.1%	COM	38341P102
—	CURIS INC	2,294,721	$17,968	4.4%	$8.14	—	COM NEW	231269200
IPSC	CENTURY THERAPEUTICS INC	602,623	$15,162	3.7%	$25.93	+4.4%	COM	15673T100
ARVN	ARVINAS INC	168,500	$13,847	3.4%	$34.48	+156.3%	COM	04335A105
VERA	VERA THERAPEUTICS INC	696,126	$12,078	3.0%	$15.54	+15.1%	CL A	92337R101
RNAM	AVIDITY BIOSCIENCES INC	446,641	$11,001	2.7%	$28.99	-25.0%	COM	05370A108
CTKB	CYTEK BIOSCIENCES INC	500,000	$10,705	2.6%	$23.52	0.0%	COM	23285D109
DYN	DYNE THERAPEUTICS INC	583,649	$9,478	2.3%	$19.71	-10.0%	COM	26818M108
—	CONNECT BIOPHARMA HLDGS LTD	326,143	$7,795	1.9%	$18.50	—	ADS	207523101
STOK	STOKE THERAPEUTICS INC	296,822	$7,551	1.9%	$35.35	-21.1%	COM	86150R107
—	OMEGA THERAPEUTICS INC	370,279	$6,980	1.7%	$18.85	—	COMMON STOCK	68217N105
CRDF	CARDIFF ONCOLOGY INC	982,753	$6,545	1.6%	$14.50	-56.7%	COM	14147L108
—	PROMETHEUS BIOSCIENCES INC	200,000	$4,742	1.2%	$18.26	—	COM	74349U108
—	AMBRX BIOPHARMA INC	350,000	$4,725	1.2%	$19.60	—	SPONSORED ADS	02290A102
—	IVERIC BIO INC	277,057	$4,499	1.1%	$6.91	—	COM	46583P102
—	NGM BIOPHARMACEUTICALS INC	200,000	$4,204	1.0%	$29.53	—	COM	62921N105
MLTX	HELIX ACQUISITION CORP	400,000	$3,948	1.0%	$11.37	—	COM CL A	G4444C102
—	IKENA ONCOLOGY INC	275,000	$3,471	0.9%	$28.25	—	COM	45175G108
GLUE	MONTE ROSA THERAPEUTICS INC	150,000	$3,342	0.8%	$20.37	+40.7%	COM	61225M102
PMVP	PMV PHARMACEUTICALS INC	100,141	$2,984	0.7%	$39.23	-18.6%	COM	69353Y103
—	JIYA ACQUISITION CORP	300,000	$2,934	0.7%	$10.30	—	COM CL A	47760M102
EWTX	EDGEWISE THERAPEUTICS INC	50,000	$830	0.2%	$32.43	-44.2%	COM	28036F105
DSGN	DESIGN THERAPEUTICS INC	14,926	$219	0.1%	$31.14	-46.6%	COM	25056L103
—	TENAX THERAPEUTICS INC	30,600	$54	0.0%	$1.76	—	COM NEW	88032L209